Delta4 expands Team and tackles new indications
A Welcome to Our Newest Member Following our Financing in March 2021 and our move into new premises in July 2021, we are continuing to expand our footprint and our capabilities. To that effect, I am happy to announce that Samuel Walter has joined the team as Data Scientist. Samuel will finish his Ph.D. in […]
BIO-Europe 2020 Digital – Partnering Event
Global connections are more important than ever. With the same powerful one-to-one partnering and valuable content, BIO-Europe Digital continues to help you drive your life science partnering forward. For more information on the conference, please visit the official webpage. Delta4 will be there! Schedule an online chat with us for a discussion around our offers, […]
Press Release – June 2020
Delta4 Announces Results Achieved with Drug Discovery Platform Vienna, Europe (June 2, 2020) – Delta4, a biotech company using its proven digital drug discovery platform to identify new indications for approved drugs, today announced recent results achieved in two drug discovery and development programs. In its lead program, which aims at developing a therapy for […]
COVID-19 – Call to Action
The global crisis caused by the SARS-Cov2 outbreak requires rapidly applicable therapeutics. Available approved drug substances represent one of the more realistic paths to clinical use within weeks or months. Delta4 is aiming to use its digital drug development platform to screen repurposing opportunities for COVID-19. Currently our computational biology staff is preparing to curate […]
Biotech Showcase 2020 @JPM San Francisco
What Is It? Biotech Showcase™ is an investor conference during JPM 2020, devoted to providing private and public biotech companies and life sciences companies with an opportunity to present to and meet with investors and pharmaceutical executives in one place during the course of one of the industry’s largest annual healthcare investor conferences. The conference […]